Rare Disease & Gene Therapy Digest May 28, 2026 The FDA approved AbbVie’s DECNUPAZ (pivekimab sunirine-pvzy) on May…
Rare Disease & Gene Therapy Membership Required
You must be a Rare Disease & Gene Therapy member to access this content.
Already a member? Log in here